Mohamed El-Dib, M.B.,B.Ch., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypothermia, Induced | 22 | 2023 | 747 | 8.130 |
Why?
|
Hypoxia-Ischemia, Brain | 21 | 2023 | 326 | 8.060 |
Why?
|
Infant, Newborn, Diseases | 18 | 2023 | 580 | 7.180 |
Why?
|
Brain Injuries | 10 | 2023 | 2024 | 2.800 |
Why?
|
Brain Diseases | 7 | 2023 | 1554 | 2.680 |
Why?
|
Infant, Very Low Birth Weight | 7 | 2017 | 406 | 2.150 |
Why?
|
Infant, Newborn | 63 | 2023 | 25575 | 1.790 |
Why?
|
Infant, Premature | 18 | 2023 | 2041 | 1.730 |
Why?
|
Asphyxia Neonatorum | 7 | 2021 | 107 | 1.640 |
Why?
|
Infant, Premature, Diseases | 5 | 2022 | 706 | 1.450 |
Why?
|
Electroencephalography | 13 | 2022 | 6142 | 1.040 |
Why?
|
Infant | 25 | 2023 | 35070 | 0.820 |
Why?
|
Cerebrovascular Circulation | 5 | 2022 | 2732 | 0.800 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2022 | 103 | 0.790 |
Why?
|
Neonatology | 1 | 2023 | 121 | 0.780 |
Why?
|
Oxygen Consumption | 2 | 2019 | 1869 | 0.760 |
Why?
|
Cerebral Hemorrhage | 3 | 2022 | 2643 | 0.720 |
Why?
|
Phenobarbital | 2 | 2017 | 192 | 0.710 |
Why?
|
Intensive Care Units, Neonatal | 10 | 2023 | 778 | 0.700 |
Why?
|
Neurologic Examination | 5 | 2020 | 931 | 0.680 |
Why?
|
Seizures | 7 | 2022 | 2851 | 0.640 |
Why?
|
Cerebral Ventricles | 1 | 2020 | 544 | 0.610 |
Why?
|
Oxygen | 6 | 2023 | 4169 | 0.600 |
Why?
|
Brain | 16 | 2022 | 26343 | 0.540 |
Why?
|
Developmental Disabilities | 6 | 2013 | 1452 | 0.540 |
Why?
|
Brain Chemistry | 1 | 2019 | 981 | 0.510 |
Why?
|
Water Pollutants, Chemical | 8 | 2001 | 311 | 0.500 |
Why?
|
Gestational Age | 11 | 2023 | 3490 | 0.480 |
Why?
|
Child Development | 4 | 2013 | 2222 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 14 | 2023 | 35342 | 0.410 |
Why?
|
Voice | 1 | 2015 | 259 | 0.410 |
Why?
|
Spectroscopy, Near-Infrared | 6 | 2021 | 721 | 0.400 |
Why?
|
Brain Damage, Chronic | 1 | 2011 | 265 | 0.370 |
Why?
|
Monitoring, Physiologic | 7 | 2022 | 1737 | 0.360 |
Why?
|
Wakefulness | 2 | 2013 | 1243 | 0.340 |
Why?
|
Echoencephalography | 3 | 2022 | 135 | 0.330 |
Why?
|
Eukaryota | 2 | 2001 | 100 | 0.330 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2566 | 0.330 |
Why?
|
Thrombosis | 1 | 2022 | 2966 | 0.320 |
Why?
|
Humans | 65 | 2023 | 742088 | 0.320 |
Why?
|
Anticonvulsants | 1 | 2017 | 1914 | 0.300 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.290 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2011 | 340 | 0.290 |
Why?
|
Fresh Water | 4 | 2001 | 83 | 0.280 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 565 | 0.270 |
Why?
|
Heart Rate | 2 | 2019 | 4091 | 0.260 |
Why?
|
Oximetry | 3 | 2019 | 467 | 0.250 |
Why?
|
Mothers | 1 | 2015 | 2163 | 0.250 |
Why?
|
Chlorophyll | 2 | 2001 | 27 | 0.240 |
Why?
|
Insecticides | 3 | 1996 | 195 | 0.240 |
Why?
|
Hydrocarbons, Halogenated | 2 | 1994 | 20 | 0.230 |
Why?
|
Hypocapnia | 1 | 2022 | 34 | 0.210 |
Why?
|
Neuroprotective Agents | 2 | 2022 | 941 | 0.210 |
Why?
|
Leukomalacia, Periventricular | 1 | 2023 | 183 | 0.210 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 26 | 0.200 |
Why?
|
Azides | 1 | 2021 | 116 | 0.200 |
Why?
|
Fuel Oils | 1 | 2001 | 34 | 0.200 |
Why?
|
Retrospective Studies | 11 | 2023 | 77098 | 0.200 |
Why?
|
Pesticide Residues | 3 | 1996 | 95 | 0.190 |
Why?
|
Phlebography | 1 | 2022 | 333 | 0.190 |
Why?
|
Infant, Small for Gestational Age | 2 | 2015 | 440 | 0.190 |
Why?
|
Intensive Care, Neonatal | 1 | 2022 | 197 | 0.190 |
Why?
|
Water Supply | 2 | 1992 | 214 | 0.190 |
Why?
|
Spectrum Analysis | 1 | 2022 | 451 | 0.180 |
Why?
|
Sleep | 2 | 2013 | 4604 | 0.180 |
Why?
|
Apgar Score | 1 | 2020 | 123 | 0.180 |
Why?
|
District of Columbia | 2 | 2017 | 157 | 0.170 |
Why?
|
Melatonin | 2 | 2015 | 720 | 0.170 |
Why?
|
Head | 2 | 2022 | 878 | 0.170 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5705 | 0.170 |
Why?
|
Dilatation | 1 | 2020 | 286 | 0.170 |
Why?
|
Maternal Age | 2 | 2019 | 802 | 0.160 |
Why?
|
Egypt | 9 | 2015 | 100 | 0.160 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 3507 | 0.150 |
Why?
|
Chlorophyta | 2 | 1994 | 15 | 0.150 |
Why?
|
Petroleum | 1 | 1997 | 76 | 0.150 |
Why?
|
Carbon Dioxide | 3 | 2019 | 1141 | 0.150 |
Why?
|
Malathion | 1 | 1996 | 6 | 0.150 |
Why?
|
Tilapia | 1 | 1996 | 24 | 0.150 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 34 | 0.140 |
Why?
|
Vasoconstriction | 1 | 2019 | 596 | 0.140 |
Why?
|
Caffeine | 1 | 2021 | 699 | 0.140 |
Why?
|
Water Pollutants | 3 | 1985 | 26 | 0.140 |
Why?
|
GABA Modulators | 1 | 1996 | 107 | 0.140 |
Why?
|
Hydrocarbons, Brominated | 2 | 1994 | 28 | 0.140 |
Why?
|
Prospective Studies | 12 | 2023 | 53187 | 0.140 |
Why?
|
Chloroform | 2 | 1994 | 28 | 0.140 |
Why?
|
Seawater | 3 | 1985 | 121 | 0.130 |
Why?
|
Midazolam | 1 | 2017 | 270 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 944 | 0.130 |
Why?
|
Fructose | 1 | 2017 | 288 | 0.130 |
Why?
|
Tracheitis | 1 | 2015 | 28 | 0.130 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2017 | 209 | 0.130 |
Why?
|
Female | 27 | 2023 | 379592 | 0.130 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1613 | 0.120 |
Why?
|
Lidocaine | 1 | 2017 | 542 | 0.120 |
Why?
|
Temperature | 4 | 2016 | 2207 | 0.120 |
Why?
|
Length of Stay | 2 | 2020 | 6294 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1459 | 0.120 |
Why?
|
Birth Weight | 3 | 2020 | 2068 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3528 | 0.110 |
Why?
|
Water Microbiology | 1 | 1994 | 117 | 0.110 |
Why?
|
Prognosis | 6 | 2021 | 29010 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15530 | 0.110 |
Why?
|
Male | 24 | 2021 | 349538 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2019 | 1126 | 0.110 |
Why?
|
Chlorine | 1 | 1992 | 50 | 0.110 |
Why?
|
Polychlorinated Biphenyls | 2 | 1985 | 245 | 0.110 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2013 | 89 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2019 | 1296 | 0.110 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1525 | 0.110 |
Why?
|
Patient Positioning | 1 | 2015 | 322 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3760 | 0.100 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 570 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1499 | 0.100 |
Why?
|
Pregnancy Trimester, Third | 1 | 2014 | 571 | 0.100 |
Why?
|
Chromatography, Gas | 2 | 2009 | 156 | 0.100 |
Why?
|
Respiratory Mucosa | 1 | 2015 | 427 | 0.100 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 1992 | 128 | 0.100 |
Why?
|
Biological Clocks | 1 | 2013 | 322 | 0.100 |
Why?
|
Water Pollution, Chemical | 3 | 1985 | 31 | 0.100 |
Why?
|
Gastrointestinal Agents | 1 | 2015 | 494 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2011 | 15056 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 632 | 0.090 |
Why?
|
Psychomotor Disorders | 1 | 2011 | 152 | 0.090 |
Why?
|
Massachusetts | 1 | 2023 | 8662 | 0.090 |
Why?
|
Pesticides | 2 | 2009 | 287 | 0.090 |
Why?
|
Pregnancy | 5 | 2023 | 29087 | 0.090 |
Why?
|
Critical Care | 1 | 2022 | 2640 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1532 | 0.090 |
Why?
|
Critical Illness | 1 | 2022 | 2665 | 0.090 |
Why?
|
Linear Models | 2 | 2019 | 5948 | 0.090 |
Why?
|
Magnesium | 1 | 2013 | 813 | 0.090 |
Why?
|
Retinopathy of Prematurity | 1 | 2014 | 421 | 0.090 |
Why?
|
Risk | 2 | 2019 | 9679 | 0.080 |
Why?
|
Trachea | 1 | 2015 | 1075 | 0.080 |
Why?
|
Hemodynamics | 1 | 2019 | 4197 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2019 | 62966 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 5 | 2021 | 2552 | 0.080 |
Why?
|
Methyl Parathion | 2 | 1984 | 7 | 0.080 |
Why?
|
Parathion | 2 | 1984 | 14 | 0.080 |
Why?
|
Waste Disposal, Fluid | 1 | 1987 | 30 | 0.080 |
Why?
|
Sewage | 1 | 1987 | 40 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2022 | 3839 | 0.080 |
Why?
|
Registries | 1 | 2023 | 8077 | 0.080 |
Why?
|
Textile Industry | 1 | 1987 | 74 | 0.080 |
Why?
|
Ibuprofen | 1 | 2009 | 235 | 0.070 |
Why?
|
Wood | 1 | 1987 | 88 | 0.070 |
Why?
|
Palliative Care | 1 | 2022 | 3478 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 802 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1884 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3301 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1788 | 0.070 |
Why?
|
Ascorbic Acid | 1 | 2009 | 647 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2015 | 2795 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2014 | 1368 | 0.060 |
Why?
|
Coloring Agents | 1 | 1987 | 565 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2372 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4229 | 0.060 |
Why?
|
Premature Birth | 1 | 2015 | 1713 | 0.060 |
Why?
|
Trihalomethanes | 2 | 1994 | 23 | 0.060 |
Why?
|
Movement | 1 | 2010 | 1470 | 0.060 |
Why?
|
Ultrasonography | 1 | 2016 | 5978 | 0.050 |
Why?
|
Fishes | 2 | 1985 | 569 | 0.050 |
Why?
|
Water | 1 | 2009 | 1388 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2015 | 21719 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2009 | 1548 | 0.050 |
Why?
|
Young Adult | 5 | 2023 | 56350 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8925 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2861 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19862 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2015 | 3861 | 0.050 |
Why?
|
Antioxidants | 1 | 2009 | 1659 | 0.050 |
Why?
|
Cohort Studies | 4 | 2023 | 40450 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 2410 | 0.050 |
Why?
|
Adult | 6 | 2023 | 213712 | 0.050 |
Why?
|
Blood Glucose | 1 | 2014 | 6249 | 0.040 |
Why?
|
Water Pollution | 2 | 1971 | 32 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14720 | 0.040 |
Why?
|
Sucrose | 1 | 2020 | 164 | 0.040 |
Why?
|
Blood Pressure | 1 | 2015 | 8541 | 0.040 |
Why?
|
United States | 4 | 2021 | 69693 | 0.040 |
Why?
|
Animals | 6 | 2019 | 168561 | 0.040 |
Why?
|
Gills | 1 | 1996 | 21 | 0.040 |
Why?
|
Fentanyl | 1 | 2020 | 410 | 0.040 |
Why?
|
Nephelometry and Turbidimetry | 1 | 1996 | 91 | 0.040 |
Why?
|
Biotransformation | 1 | 1996 | 168 | 0.040 |
Why?
|
Partial Pressure | 1 | 2016 | 253 | 0.040 |
Why?
|
Indomethacin | 1 | 2017 | 331 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6722 | 0.030 |
Why?
|
Ligation | 1 | 2017 | 453 | 0.030 |
Why?
|
Child | 3 | 2022 | 77478 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1996 | 361 | 0.030 |
Why?
|
Morphine | 1 | 2020 | 657 | 0.030 |
Why?
|
Culture Media | 1 | 1997 | 902 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 1996 | 272 | 0.030 |
Why?
|
Carbohydrates | 1 | 1997 | 391 | 0.030 |
Why?
|
Dexmedetomidine | 1 | 2020 | 315 | 0.030 |
Why?
|
Pepsin A | 1 | 2015 | 71 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2017 | 371 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2593 | 0.030 |
Why?
|
Fetal Blood | 1 | 2021 | 1317 | 0.030 |
Why?
|
Colorimetry | 2 | 1972 | 147 | 0.030 |
Why?
|
Supine Position | 1 | 2015 | 204 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2935 | 0.030 |
Why?
|
Obstetric Labor, Premature | 1 | 2015 | 279 | 0.030 |
Why?
|
Term Birth | 1 | 2014 | 135 | 0.030 |
Why?
|
Diatoms | 1 | 1993 | 14 | 0.030 |
Why?
|
Body Fluids | 1 | 2015 | 319 | 0.030 |
Why?
|
Cyanobacteria | 1 | 1993 | 44 | 0.030 |
Why?
|
Hospitals, University | 1 | 2015 | 571 | 0.030 |
Why?
|
Herbicides | 1 | 1993 | 98 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 20928 | 0.030 |
Why?
|
Time Factors | 3 | 2011 | 40054 | 0.030 |
Why?
|
Rewarming | 1 | 2012 | 61 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13921 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7276 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1996 | 2335 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 596 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1158 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2023 | 2736 | 0.020 |
Why?
|
Muscles | 1 | 1996 | 1617 | 0.020 |
Why?
|
Morbidity | 1 | 2017 | 1767 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2008 | 4566 | 0.020 |
Why?
|
Urine | 1 | 2012 | 370 | 0.020 |
Why?
|
Triazines | 1 | 1993 | 316 | 0.020 |
Why?
|
Child, Preschool | 2 | 2011 | 40955 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 7716 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1996 | 3701 | 0.020 |
Why?
|
Aniline Compounds | 2 | 1972 | 983 | 0.020 |
Why?
|
Anilides | 1 | 1972 | 404 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39004 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 1972 | 526 | 0.020 |
Why?
|
United States Environmental Protection Agency | 1 | 2009 | 139 | 0.020 |
Why?
|
Hydrolysis | 2 | 1984 | 682 | 0.020 |
Why?
|
Adsorption | 1 | 1987 | 201 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4929 | 0.020 |
Why?
|
Intestines | 1 | 1996 | 1923 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 1916 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20086 | 0.020 |
Why?
|
Sodium Chloride | 2 | 1984 | 625 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2015 | 2014 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1492 | 0.020 |
Why?
|
Industrial Waste | 1 | 1966 | 23 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2450 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 1760 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2014 | 2128 | 0.020 |
Why?
|
DDT | 1 | 1985 | 31 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1996 | 3038 | 0.020 |
Why?
|
Pain | 1 | 2020 | 4961 | 0.020 |
Why?
|
Biodegradation, Environmental | 1 | 1984 | 219 | 0.010 |
Why?
|
Drug Stability | 1 | 1984 | 290 | 0.010 |
Why?
|
Carbon | 1 | 1987 | 686 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3667 | 0.010 |
Why?
|
Particle Size | 1 | 1987 | 1640 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12242 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1617 | 0.010 |
Why?
|
Proteins | 1 | 1997 | 6096 | 0.010 |
Why?
|
Azo Compounds | 2 | 1972 | 113 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3527 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13403 | 0.010 |
Why?
|
Methods | 2 | 1972 | 1128 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8297 | 0.010 |
Why?
|
Adolescent | 3 | 2015 | 85649 | 0.010 |
Why?
|
Liver | 1 | 1996 | 7470 | 0.010 |
Why?
|
Risk Factors | 3 | 2014 | 72145 | 0.010 |
Why?
|
Insulin | 1 | 2015 | 6575 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13853 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6483 | 0.010 |
Why?
|
Kinetics | 1 | 1984 | 6474 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13256 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12017 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 24913 | 0.010 |
Why?
|
Naphthols | 1 | 1971 | 45 | 0.010 |
Why?
|
Resorcinols | 1 | 1971 | 38 | 0.010 |
Why?
|
Amines | 1 | 1971 | 278 | 0.010 |
Why?
|
Amides | 1 | 1972 | 458 | 0.010 |
Why?
|
Phenols | 1 | 1971 | 501 | 0.000 |
Why?
|
Middle Aged | 1 | 2015 | 213127 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1966 | 2187 | 0.000 |
Why?
|